ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis

Creators: Hojsak, Iva and Colomb, Virginie and Braegger, Christian and Bronsky, Jiri and Campoy, Cristina and Domellöf, Magnus and Embleton, Nicholas D. and Fidler Mis, Natasa and Hulst, Jessie M. and Indrio, Flavia and Lapillone, Alexandre and Mihatsch, Walter and Molgaard, Christian and Van Goudoever, Johannes B. and Fewtrell, Mary and ESPGHAN Committee on Nutrition
Title: ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis
Item Type: Article or issue of a publication series
Journal or Series Title: Journal of Pediatric Gastroenterology and Nutrition : JPGN
Page Range: pp. 776-792
Date: May 2016
Divisions: Gesundheitsmanagement
Abstract: The aim of the present article was to perform a systematic review with meta-analysis of available scientific evidence regarding the role of different intravenous lipid emulsions (ILE) in the pathogenesis of cholestasis and parenteral nutrition-associated liver disease. A systematic review of the literature (up to March 2015) identified 23 randomized controlled trials (RCTs). Of these, 17 were performed in preterm infants or critically ill neonates with a short duration of intervention, 2 in older children with short-term use (following surgery or bone marrow transplantation), 1 in neonates with long-term use, and 3 in infants and children receiving long-term parenteral nutrition (PN). Meta-analysis showed no differences in the rate of cholestasis or bilirubin levels associated with short-term use of different ILEs. Because of high heterogeneity of the long-term studies no meta-analysis could be performed. Available studies found that the use of multicomponent fish oil (FO)-containing ILE compared with pure soya bean oil (SO), ILE-reduced liver enzymes, and bilirubin levels in noncholestatic children on long-term PN and one other RCT found that FO-based ILE-reversed cholestasis in a proportion of patients. The ESPGHAN Committee on Nutrition concludes that there is no evidence of a difference in rates of cholestasis or bilirubin levels between different ILE for short-term use in neonates. The use of multicomponent FO-containing ILE may contribute to a decrease in total bilirubin levels in children with IF on prolonged PN. Well-designed RCTs are, however, lacking and long-term effects have not been determined.
Forthcoming: No
Citation:

Hojsak, Iva and Colomb, Virginie and Braegger, Christian and Bronsky, Jiri and Campoy, Cristina and Domellöf, Magnus and Embleton, Nicholas D. and Fidler Mis, Natasa and Hulst, Jessie M. and Indrio, Flavia and Lapillone, Alexandre and Mihatsch, Walter and Molgaard, Christian and Van Goudoever, Johannes B. and Fewtrell, Mary and ESPGHAN Committee on Nutrition (2016) ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis. Journal of Pediatric Gastroenterology and Nutrition : JPGN, 62 (5). pp. 776-792. ISSN 0277-2116

Actions (login required)

View Item View Item